Adjusted* prevalence risk ratios (PRs) of detectable plasma HIV RNA and mean differences in plasma HIV RNA and CD4+ T cell counts (from the cross-sectional log binomial and linear regression models at the 3^rd visit) by degree of HSV-2 clinical activity.

Note: CI, confidence interval; PR, prevalence ratio; P, p-value; SR GH, self reported genital herpes; L-V, lesion-visit; *adjusted for baseline CD4+ T cell count, herpes medications and type of antiretroviral therapy used at the visit, age, race, lifetime number of sexual partners, injection and noninjection drug use; †positive self report of genital herpes only; ‡number of visits with lesions.